Stock Track | Intellia Therapeutics Soars 6.24% in Pre-market on Analyst Bullish Call

Stock Track
03/02

Intellia Therapeutics (NTLA) stock soared 6.24% in pre-market trading on Monday, showing significant upward momentum ahead of the regular session.

The surge appears driven by a positive analyst action, with H.C. Wainwright analyst Mitchell Kapoor reiterating a Buy rating on the company and setting a price target of $25.00.

Such analyst endorsements often influence investor sentiment, particularly in pre-market activity, as they provide forward-looking assessments of a company's value and prospects.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10